文献速递慢阻肺呼吸道感染

慢阻肺、支气管扩张及两者关联的内型分析

Endotyping Chronic Obstructive Pulmonary Disease, Bronchiectasis, and the "Chronic Obstructive Pulmonary Disease-Bronchiectasis Association".
PubMed 文献 · Am J Respir Crit Care Med · 2022-01-01

该研究对慢阻肺(n=43)、支气管扩张(n=30)及慢阻肺-支气管扩张关联(n=48)患者的痰微生物组和蛋白质组进行分析,并在独立队列(n=91)中验证。结果显示关联组以中性粒细胞炎症、MUC5AC高表达和革兰阴性菌感染为特征,与慢阻肺组部分分离,与支气管扩张组高度重叠,并提出五种内型。

要点

  • 慢阻肺-支气管扩张关联组以中性粒细胞脱颗粒通路和MUC5AC高表达为特征。
  • 慢阻肺组则表现为MUC5B和肽酶抑制剂高表达、微生物多样性更高。
  • 关联组与支气管扩张组的微生物组和蛋白质组谱高度重叠。

核心结论

  • 中性粒细胞炎症、差异黏蛋白表达和革兰阴性菌感染是慢阻肺-支气管扩张关联患者的主要特征。

研究设计与样本

  • 研究采用16S rRNA扩增子测序和无标记蛋白质组学分析痰微生物组和蛋白质组。
  • 发现队列包括慢阻肺43例、支气管扩张30例和慢阻肺-支气管扩张关联48例。
  • 结果在独立队列91例(每组28-31例)中通过靶向测量炎症标志物、黏蛋白和细菌培养进行验证。

主要发现

  • 主成分分析显示慢阻肺组与慢阻肺-支气管扩张关联组部分分离。
  • 关联组较慢阻肺组有更高丰度的变形菌门、更高表达的MUC5AC和中性粒细胞脱颗粒通路蛋白。
  • 慢阻肺组有更高表达的MUC5B和几种肽酶抑制剂、更高丰度的常见共生菌群和更高的微生物多样性。
  • 关联组与支气管扩张组的谱型大部分重叠。
  • 研究提出五种内型,具有不同的炎症、黏蛋白和微生物学特征。

关键数值与推荐

  • 关联组关键特征在独立队列中得到验证。

临床怎么用

  • 对慢阻肺-支气管扩张关联患者,可关注中性粒细胞炎症、MUC5AC表达和革兰阴性菌感染特征以指导治疗。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Rationale: Bronchiectasis and chronic obstructive pulmonary disease (COPD) are two disease entities with overlapped clinical features, and codiagnosis frequently occurs (termed the "COPD-bronchiectasis association"). Objectives: To investigate the sputum microbiome and proteome in patients with bronchiectasis, COPD, and the COPD-bronchiectasis association with the aim of identifying endotypes that may inform treatment. Methods: Sputum microbiome and protein profiling were carried out using 16S rRNA amplicon sequencing and a label-free proteomics workflow, respectively, in a cohort comprising patients with COPD (n = 43), bronchiectasis (n = 30), and the COPD-bronchiectasis association (n = 48). Results were validated in an independent cohort of 91 patients (n = 28-31 each group) using targeted measurements of inflammatory markers, mucins, and bacterial culture. Measurements and Main Results: Principal component analysis of sputum microbiome and protein profiles showed a partial separation between the COPD and the "COPD-bronchiectasis association" group. Further analyses revealed that patients with the "COPD-bronchiectasis association" had a higher abundance of proteobacteria, higher expression of mucin-5AC and proteins from the "neutrophil degranulation" pathway compared to those with COPD. In contrast, patients with COPD had an elevated expression of mucin-5B and several peptidase inhibitors, higher abundance of common commensal taxa, and a greater microbiome diversity. The profiles of "COPD-bronchiectasis association" and bronchiectasis groups were largely overlapping. Five endotypes were proposed with differential inflammatory, mucin, and microbiological features. The key features related to the "COPD-bronchiectasis association" were validated in an independent cohort. Conclusions: Neutrophilic inflammation, differential mucin expression, and Gram-negative infection are dominant traits in patients with the "COPD-bronchiectasis association."

来源:Am J Respir Crit Care Med,查看原文。版权归原作者所有。

引用

  1. Huang JT, Cant E, Keir HR, et al. Endotyping Chronic Obstructive Pulmonary Disease, Bronchiectasis, and the "Chronic Obstructive Pulmonary Disease-Bronchiectasis Association". Am J Respir Crit Care Med. 2022. PMID: 35436182. doi:10.1164/rccm.202108-1943OC

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。